Tim Opler@TimOplerFeb 3, 2023Replying to @BertrandBio @BiotechCH and 8 othersmckinsey.comFive ways biopharma companies can navigate the deal landscapeThe biopharma industry investment landscape is changing. Companies that grasp macro trends in M&A deal making could position themselves well for opportunities.333314143.1K3.1K
Tim Opler@TimOplerJan 8, 2025Replying to @damienics and @bradloncarstifel.com/Newsletters/In…22111313660660
